Alzheimer’s drug studied at Butler Hospital shows early promise

RESULTS OF clinical trial of a Alzheimer's disease treatment studied at Butler Hospital showed it could potentially be used to slow the symptoms of the disease. / COURTESY BUTLER HOSPITAL
PROVIDENCE – The results of clinical trials of an investigational drug to treat Alzheimer’s disease studied at Butler Hospital showed significant results in people with early symptomatic AD, Care New England Health System announced Monday. The results, published in the New England Journal of Medicine, showed that the drug, donanemab, holds promise as a potential…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display